Peptide Referee

Livagen: research, legal status and who sells it

This page is information, not medical advice. Livagen is not approved as a medicine in the markets below unless stated. We don't publish dosing or usage instructions.

Also known as
Lys-Glu-Asp-Ala, KEDA peptide
Category
Synthetic tetrapeptide (Khavinson peptide bioregulator)
Evidence level
Preclinical (lab and animal studies)
Price range
$1.25/mg to $4.00/mg, median $2.72/mg across 7 vendors (compare)
Our lab tests
None yet (how testing will work)
WhereStatus
United StatesNo FDA-approved drug contains livagen [1].
United KingdomNo UK-licensed medicine containing livagen appears in the MHRA products database [2].
European UnionNo medicine containing livagen is authorized in the EU, according to EMA's central and Article 57 product data [3][4].
CanadaNo product containing livagen appears in Health Canada's Drug Product Database [5].
AustraliaLivagen is not named in Australia's Poisons Standard (October 2026) [6].
Sport (WADA)Not named on the 2026 Prohibited List; its section S0 bans any pharmacological substance with no current approval for human therapeutic use [7].
 Summaries of official sources, checked —. Rules change; follow the source links. Not legal advice.

We haven't published a full overview of Livagen yet. The legal status table and live prices on this page are current.

Livagen prices: cheapest listings

The five lowest $/mg listings out of 8. See all Livagen prices

Vendor Transparency Product Size Price $/mg vs median Stock Vendor's page
Bulk Peptide Wholesale 45/100* Livagen 20 mg (10 vials) 20 mg × 10 $250 $1.25/mg −54% In stock View
Bulk Peptide Supply 57/100* LIVAGEN 20 MG (10 VIALS) 20 mg × 10 $400 $2.00/mg −27% In stock View
Go Alpha Labs 83/100 Livagen (20mg) (10 Vials) 20 mg × 10 $490 $2.45/mg −10% In stock View
Modern Aminos 77/100 LIVAGEN 20MG 20 mg $54 $2.70/mg −1% In stock View
Pure Lab Peptides 82/100 Livagen 20mg 20 mg $55 $2.75/mg +1% In stock View

Prices come from each vendor's public product feed and were last fetched Oct 15, 2026. They exclude shipping and discounts. $/mg uses the labeled amount, not measured content. A transparency score marked * is based on fewer than six checks; checks we couldn't complete score 0. How we compare prices.

Sources

  1. Drugs@FDA: FDA-Approved Drugs (database searched by active ingredient). U.S. Food and Drug Administration. Accessed Oct 15, 2026
  2. MHRA Products: licensed-medicine search for "livagen". Medicines and Healthcare products Regulatory Agency (UK). Accessed Oct 15, 2026
  3. EMA medicines data: centrally authorised human medicines (export of 14 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  4. EMA Article 57 product data: medicines authorised in the EU/EEA (data as of 9 October 2026). European Medicines Agency. Accessed Oct 15, 2026
  5. Drug Product Database online query (searched by active ingredient). Health Canada. Accessed Oct 15, 2026
  6. Therapeutic Goods (Poisons Standard—October 2026) Instrument 2026 (F2026L01327, registered 30 September 2026). Federal Register of Legislation, Australian Government. Accessed Oct 15, 2026
  7. World Anti-Doping Code International Standard: Prohibited List 2026 (in force 1 January 2026). World Anti-Doping Agency. Accessed Oct 15, 2026
  8. The influence of polypeptide liver complex and tetrapeptide KEDA on organism physiological function in norm and age-related pathology (in Russian). Advances in Gerontology (Uspekhi Gerontologii) (2020). Accessed Oct 15, 2026
  9. Transport of Biologically Active Ultrashort Peptides Using POT and LAT Carriers. International Journal of Molecular Sciences (2022). Accessed Oct 15, 2026